VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Longitudinal Outcomes of DBS in PD

Active, not recruiting

Conditions: Parkinson Disease

First Posted Date: 2018-07-10

Last Posted Date: 2024-03-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 50

Registration Number: NCT03582163

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Mechanisms of Mindfulness-based Interventions

Conditions: Depression
Stress
Anxiety

Interventions: Behavioral: Mindfulness-based Stress Reduction (MBSR)
Behavioral: Mindfulness-based Cognitive Therapy (MBCT)

First Posted Date: 2018-06-27

Last Posted Date: 2021-11-09

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 90

Registration Number: NCT03571386

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)

Not Applicable

Terminated

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Other: Usual Care of IPF
Other: Telenursing
Other: Telenursing and Remote Monitoring

First Posted Date: 2018-06-19

Last Posted Date: 2024-01-16

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 31

Registration Number: NCT03562247

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

SeRenade Parent-Child Music Class Program

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: SeRenade Parent-Child Music Class
Behavioral: Delayed Intervention

First Posted Date: 2018-06-18

Last Posted Date: 2022-02-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 70

Registration Number: NCT03560297

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Promotora Navigator - Culturally Appropriate Patient Navigator

Not Applicable

Completed

Conditions: Screening Mammography
Breast Cancer
Community Health Worker

Interventions: Other: Standard of Care Mammography
Behavioral: Mammography with Community Health Worker (individual)
Behavioral: Mammography with Community Health Worker (group)

First Posted Date: 2018-06-15

Last Posted Date: 2019-08-14

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 101

Registration Number: NCT03557801

Locations: 🇺🇸
Matthew Walker Comprehensive Health Center, Nashville, Tennessee, United States

Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).

Phase 4

Completed

Conditions: Left Atrial Appendage Thrombosis
Watchman LAA Closure Device
Atrial Fibrillation
Device Related Thrombus

Interventions: Drug: Dabigatran Etexilate Oral Capsule

First Posted Date: 2018-05-29

Last Posted Date: 2024-05-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT03539055

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Balanced Solutions and Plasma Electrolytes

Not Applicable

Completed

Conditions: Acidosis, Metabolic
Critical Illness

Interventions: Other: Lactated Ringer's
Other: Normosol

First Posted Date: 2018-05-25

Last Posted Date: 2019-10-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2093

Registration Number: NCT03537898

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pragmatic Investigation of optimaL Oxygen Targets Trial

Not Applicable

Completed

Conditions: Respiratory Failure

Interventions: Other: Lower SpO2 Target
Other: Intermediate SpO2 Target
Other: Higher SpO2 Target

First Posted Date: 2018-05-25

Last Posted Date: 2023-09-25

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2541

Registration Number: NCT03537937

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

Phase 2

Completed

Conditions: Hypertension
Lung Diseases
Estrogen Receptor Antagonist
Pulmonary Arterial Hypertension
Tamoxifen
Familial Primary Pulmonary Hypertension
Primary Pulmonary Hypertension
Hormone Antagonists
Estrogens

Interventions: Drug: Placebo Oral Tablet
Drug: Tamoxifen

First Posted Date: 2018-05-18

Last Posted Date: 2024-12-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 18

Registration Number: NCT03528902

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus

Phase 2

Recruiting

Conditions: Lupus Erythematosus, Systemic

Interventions: Drug: Placebo
Drug: Memantine

First Posted Date: 2018-05-17

Last Posted Date: 2024-05-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 80

Registration Number: NCT03527472

Locations: 🇺🇸
The Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
The University of Texas Health Science Center, Houston, Houston, Texas, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy